Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Moodys
Daiichi Sankyo
US Department of Justice
QuintilesIMS

Generated: July 22, 2019

DrugPatentWatch Database Preview

Patent: 9,701,963

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,701,963
Title:Complement component C5 iRNA compositions and methods of use thereof
Abstract: The invention relates to iRNA, e.g., double-stranded ribonucleic acid (dsRNA), compositions targeting the complement component C5 gene, and methods of using such iRNA, e.g., dsRNA, compositions to inhibit expression of C5 and to treat subjects having a complement component C5-associated disease, e.g., paroxysmal nocturnal hemoglobinuria.
Inventor(s): Fitzgerald; Kevin (Brookline, MA), Butler; James (Lynnfield, MA), Bettencourt; Brian (Groton, MA), Borodovsky; Anna (Melrose, MA), Kuchimanchi; Satyanarayana (Acton, MA), Charisse; Klaus (Acton, MA), Manoharan; Muthiah (Weston, MA), Maier; Martin (Belmont, MA), Rajeev; Kallanthottathil G. (Wayland, MA), Foster; Donald (Attleboro, MA)
Assignee: Alnylam Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:15/151,568
Patent Claims:see list of patent claims

Details for Patent 9,701,963

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Try a Free Trial Alnylam Pharmaceuticals, Inc. (Cambridge, MA) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,701,963

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2014160129 Dec 04, 2014
World Intellectual Property Organization (WIPO) 2014160129 Oct 02, 2014
Uruguay 35442 Oct 31, 2014
United States of America 2015247143 Sep 03, 2015
United States of America 2016108401 Apr 21, 2016
United States of America 2016244763 Aug 25, 2016
United States of America 2017268005 Sep 21, 2017
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
US Department of Justice
Cantor Fitzgerald
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.